SCHEMBL13443579

SCHEMBL13443579

Cc1cc(C)cc(-n2c3ccccc3c3cc(-c4ccc(-c5ccc6c(c5)C(C)(C)c5cc(-c7ccc(-c8ccc9c(c8)c8ccccc8n9-c8cc(C)cc(C)c8)cc7)ccc5-6)cc4)ccc32)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TSPO P30536 2/20 0.34
▸ PGR P06401 1/20 0.33
▸ BRD9 Q9H8M2 1/20 0.33
▸ BRD7 Q9NPI1 1/20 0.33
▸ MAPT P10636 3/20 0.32
▸ NPY5R Q15761 2/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ PTGER4 P35408 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13443613 0.99 KDM4E (0.36) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL16314128 0.96 KDM4E (0.42) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13444409 0.96 KDM4E (0.42) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13444517 0.96 KDM4E (0.42) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13444338 0.95 KDM4E (0.41) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13444532 0.95 KDM4E (0.43) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13444559 0.95 KDM4E (0.43) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13443589 0.95 KDM4E (0.35) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13444556 0.94 KDM4E (0.42) PDK2KDM4EATML3MBTL1TSPO
SCHEMBL13443600 0.94 TUBB4A (0.33) PDK2KDM4EATML3MBTL1TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-18 — — US disclosed
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-18 — — US disclosed
EP-2138551-A2 Fluorene-derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-12-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100066241-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same IL33, ORMDL3, CCND3 PDK2 3177/4885KDM4E 4343/4885ATM 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback